Xvivo Perfusion AB (XVIPF)
30.95
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Xvivo Perfusion Total Liabilities (Quarterly) : 33.75M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.75M |
| March 31, 2026 | 31.45M |
| December 31, 2025 | 28.27M |
| September 30, 2025 | 30.14M |
| June 30, 2025 | 31.00M |
| March 31, 2025 | 20.18M |
| December 31, 2024 | 22.26M |
| September 30, 2024 | 19.24M |
| June 30, 2024 | 23.44M |
| March 31, 2024 | 23.43M |
| December 31, 2023 | 24.86M |
| September 30, 2023 | 28.44M |
| June 30, 2023 | 26.39M |
| March 31, 2023 | 28.25M |
| December 31, 2022 | 29.08M |
| September 30, 2022 | 23.42M |
| June 30, 2022 | 23.32M |
| March 31, 2022 | 24.14M |
| December 31, 2021 | 28.40M |
| September 30, 2021 | 15.07M |
| June 30, 2021 | 16.23M |
| March 31, 2021 | 16.78M |
| December 31, 2020 | 17.27M |
| September 30, 2020 | 8.626M |
| June 30, 2020 | 5.448M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.592M |
| December 31, 2019 | 6.085M |
| September 30, 2019 | 7.587M |
| June 30, 2019 | 7.642M |
| March 31, 2019 | 6.319M |
| December 31, 2018 | 5.204M |
| September 30, 2018 | 4.961M |
| June 30, 2018 | 4.618M |
| March 31, 2018 | 4.019M |
| December 31, 2017 | 4.178M |
| September 30, 2017 | 3.698M |
| June 30, 2017 | 3.411M |
| March 31, 2017 | 2.827M |
| December 31, 2016 | 3.620M |
| September 30, 2016 | 3.570M |
| June 30, 2016 | 2.828M |
| March 31, 2016 | 2.584M |
| December 31, 2015 | 2.29M |
| September 30, 2015 | 2.622M |
| June 30, 2015 | 3.047M |
| March 31, 2015 | 2.612M |
| December 31, 2014 | 3.260M |
| September 30, 2014 | 3.051M |
| June 30, 2014 | 5.900M |
| March 31, 2014 | 5.102M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Getinge AB | 2.725B |
| Paxman AB | 7.366M |
| Enovis Corp. | 2.287B |
| Edwards Lifesciences Corp. | 3.142B |
| Intuitive Surgical, Inc. | 2.579B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.09M |
| Shareholders Equity (Quarterly) | 227.34M |
| Debt to Equity Ratio | 0.0553 |
| Current Ratio | 3.860 |
| Net Debt Paydown Yield | -0.21% |